Gelion plc Discloses No Share Issuance in Half-Year Block Admission Return Ending July 2026

Overview of Gelion’s Block Admission Scheme and Regulatory Compliance

Gelion plc has filed its half-year block admission return in accordance with AIM Rules for Companies, which mandate regular disclosures on share schemes and security listings. The company operates an Existing Share Option Plan under a block listing arrangement, enabling streamlined issuance of shares for employee incentives or authorized corporate purposes without requiring individual regulatory approvals for each issuance, provided the total shares do not exceed the admitted amount.

This filing covers the period from 26 January 2026 to 26 July 2026 and reflects Gelion’s commitment to transparent capital management. Strand Hanson Limited serves as the nominated adviser, while Oberon Capital and Allenby Capital Limited act as joint brokers, supporting regulatory compliance. This routine disclosure offers shareholders and the market clear insight into the company’s share option activity and the status of unissued securities.

No Share Issuance During the Six-Month Review

The report confirms that Gelion did not issue any securities under its Existing Share Option Plan during the half-year ending 26 July 2026. This indicates that the company neither granted employee share options nor completed share-funded acquisitions or other dilutive events during this timeframe. The unchanged balance of unissued shares suggests no triggering events or a strategic choice to conserve share issuance authority.

At the beginning of the period on 26 January 2026, 7,803,267 ordinary shares of 0.1p each were available under the scheme. Since no shares were issued, this figure remained constant through 26 July 2026. No additional listing authority beyond the original 8,100,000 shares admitted under the block arrangement was granted. This static position reflects either a conservative equity issuance approach or absence of dilution requirements in early 2026.

Substantial Unissued Share Reserve of Over 7.8 Million Ordinary Shares

Gelion retains a significant reserve of unissued ordinary shares within its Existing Share Option Plan block listing. Although the company did not specify any particular corporate purpose for this reserve, the 7,803,267 shares of 0.1p each represent meaningful capacity for future employee incentives or acquisition financing. This unissued pool is the difference between the total 8,100,000 shares admitted and those unutilized at period end.

This share reserve offers Gelion flexibility in capital management, employee retention, and corporate development. Shares can be issued from this pool without further shareholder approval, subject to AIM Rules and company constitutional limits. The absence of issuance during the review period suggests Gelion either had no immediate need or chose to maintain optionality. Investors should monitor future returns for indications of share reserve utilization linked to M&A, option grants, or strategic initiatives.

Ordinary Shares with 0.1p Nominal Value

Gelion’s ordinary shares have a nominal value of 0.1p each, a common structure among AIM-listed growth and technology companies. This low nominal value facilitates issuing large share quantities without implying excessive capitalisation and supports flexible equity compensation. All 8,100,000 shares admitted under the block listing and the 7,803,267 unissued shares carry this 0.1p nominal value.

The nominal value is a technical feature distinct from market trading price and does not constrain share valuation. The filing does not disclose Gelion’s total issued share capital or shares in circulation, focusing solely on the block listing scheme.

Advisers and Nominated Adviser Responsibilities

Strand Hanson Limited acts as Gelion’s nominated and financial adviser, fulfilling responsibilities under AIM Rules including sponsorship and regulatory guidance. Christopher Raggett is the primary contact (+44 (0) 20 7409 3494). Oberon Capital and Allenby Capital Limited serve as joint brokers, providing capital markets advisory and execution services (+44 (0) 20 3179 5300 and +44 (0) 20 3328 5656 respectively). This advisory team supports Gelion’s AIM listing governance and shareholder communications.

Executive Leadership: CEO Matt Wood and CFO Amit Gupta

Matt Wood serves as Chief Executive Officer and Amit Gupta as Chief Financial Officer of Gelion plc. Their leadership roles encompass strategic direction and financial management, including oversight of the share option plan. Both executives can be contacted via Tavistock, the company’s corporate public relations adviser (+44 (0) 20 7920 3150 or [email protected]). Clear executive attribution enhances governance transparency for investors.

Compliance with AIM Rules Schedule Six Reporting

This block admission return complies fully with Schedule Six of the AIM Rules for Companies, which mandates disclosure of opening and closing balances of unissued securities, any new listing approvals, and securities issued during the period. Gelion’s filing confirms no unauthorized share issuances occurred and that the company remains within its block admission limits.

Schedule Six filings standardize reporting across AIM-listed companies, allowing investors and regulators to track share issuance activity consistently. Gelion’s next block admission return is expected within six months, continuing the audit trail of share authority usage.

Investor Considerations Regarding Zero Issuance

The absence of share issuance under Gelion’s Existing Share Option Plan in the first half of 2026 may reassure shareholders concerned about dilution. It suggests no new employee options were granted, no share-funded acquisitions completed, and no other dilutive capital events occurred during this period.

However, the retention of 7.8 million unissued shares also signals potential for significant future issuance, possibly for acquisitions, capital raising, or employee retention. Investors should watch subsequent block admission returns and corporate disclosures for signs of share reserve utilization, which could indicate strategic shifts.

Outlook: Tracking Future Block Admission Returns and Capital Activity

While this block admission return provides a snapshot as of 26 July 2026, it does not offer forward-looking guidance on the use of remaining unissued shares. Investors seeking insight into management’s capital allocation or strategic plans should consult full-year results, interim updates, or specific announcements.

The forthcoming block admission return, expected in about six months, will reveal if Gelion has drawn on its share reserve in the latter half of 2026. Any material changes in unissued shares or additional block listing approvals will warrant close analysis. Investors are encouraged to cross-reference these filings with other corporate disclosures to fully understand Gelion’s capital management and shareholder equity strategy.